Fludarabine phosphate
- Product NDC
- 45963-621
- 11-digit product format
- 459630621
- Labeler code
- 45963
- Product ID
- 45963-621_e0dcd67d-bac1-44b3-ab5f-5c539c00afea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fludarabine phosphate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA203738
- Marketing category
- ANDA
- Marketing start
- 2017-03-02
- Marketing end
- 0000-00-00
- Substance
- FLUDARABINE PHOSPHATE
- Active strength
- 25 mg/mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 45963-621-51 | 45963062151 | 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-621-51) > 2 mL in 1 VIAL, SINGLE-DOSE | 2017-03-02 | 0000-00-00 | No | No | Current |